CRISPR Therapeutics AG (CRSP)
50.76
+4.37
(+9.42%)
USD |
NASDAQ |
Nov 01, 16:00
50.80
+0.04
(+0.08%)
After-Hours: 20:00
CRISPR Therapeutics Market Cap: 4.323B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 4.323B |
| October 31, 2024 | 3.951B |
| October 30, 2024 | 4.082B |
| October 29, 2024 | 4.168B |
| October 28, 2024 | 4.234B |
| October 25, 2024 | 4.034B |
| October 24, 2024 | 4.084B |
| October 23, 2024 | 3.918B |
| October 22, 2024 | 4.091B |
| October 21, 2024 | 4.132B |
| October 18, 2024 | 4.166B |
| October 17, 2024 | 4.113B |
| October 16, 2024 | 4.173B |
| October 15, 2024 | 4.092B |
| October 14, 2024 | 4.073B |
| October 11, 2024 | 3.990B |
| October 10, 2024 | 3.866B |
| October 09, 2024 | 3.867B |
| October 08, 2024 | 3.850B |
| October 07, 2024 | 3.874B |
| October 04, 2024 | 3.864B |
| October 03, 2024 | 3.824B |
| October 02, 2024 | 3.893B |
| October 01, 2024 | 3.882B |
| September 30, 2024 | 4.001B |
| Date | Value |
|---|---|
| September 27, 2024 | 4.030B |
| September 26, 2024 | 3.959B |
| September 25, 2024 | 3.911B |
| September 24, 2024 | 3.985B |
| September 23, 2024 | 3.981B |
| September 20, 2024 | 4.103B |
| September 19, 2024 | 4.215B |
| September 18, 2024 | 4.223B |
| September 17, 2024 | 4.247B |
| September 16, 2024 | 4.066B |
| September 13, 2024 | 4.168B |
| September 12, 2024 | 3.908B |
| September 11, 2024 | 3.870B |
| September 10, 2024 | 3.883B |
| September 09, 2024 | 3.821B |
| September 06, 2024 | 3.800B |
| September 05, 2024 | 3.854B |
| September 04, 2024 | 3.835B |
| September 03, 2024 | 3.877B |
| August 30, 2024 | 4.064B |
| August 29, 2024 | 4.050B |
| August 28, 2024 | 4.044B |
| August 27, 2024 | 4.109B |
| August 26, 2024 | 4.188B |
| August 23, 2024 | 4.147B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.051B
Minimum
Mar 16 2020
15.53B
Maximum
Jan 14 2021
5.648B
Average
4.878B
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 121.60B |
| AC Immune SA | 296.82M |
| Addex Therapeutics Ltd | 11.44M |
| NLS Pharmaceutics Ltd | 13.73M |
| Molecular Partners AG | 203.08M |
Market Cap Related Metrics
| Price to Book Value | 2.182 |
| Price | 50.76 |
| Earnings Yield | -6.30% |